Back to search

Article

Endothelial Cells Promote Docetaxel Resistance of Prostate Cancer via FGF2/ERG/Akt/mTOR Signaling Pathway

2020-07-10

Abstract excerpt

<title>Abstract</title> <p>Background Docetaxel is a first-line chemotherapy for the treatment of patients with castration-resistant prostate cancer (CRPC). Despite the good initial response of docetaxel, drug resistance will inevitably occur. Mechanisms underlying docetaxel resistance are not well elaborated. Endothelial cells (ECs) have been implicated in the progression and metastasis of prostate cancer (PCa)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
15a5f67b-d22d-5ea4-b8be-2a8105aa250d
DOI
10.21203/rs.3.rs-40867/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Endothelial Cells Promote Docetaxel Resistance of Prostate Cancer via FGF2/ERG/Akt/mTOR Signaling PathwayDOI 10.21203/rs.3.rs-40867/v1
Select a neighboring publication to make it the new centre.